This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/527583-denmark-astrazeneca-johnson-suspension/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 0 | Version 1 |
|---|---|
| Denmark to continue suspension of AstraZeneca and Johnson & Johnson Covid vaccines over ‘possible harmful effects’ | Denmark to continue suspension of AstraZeneca and Johnson & Johnson Covid vaccines over ‘possible harmful effects’ |
| (2 months later) | |
| Denmark announced on Friday that it will continue to suspend its use of the AstraZeneca and Johnson & Johnson Covid-19 vaccines, citing “possible harmful effects” which are too much of a concern compared to the benefits. | Denmark announced on Friday that it will continue to suspend its use of the AstraZeneca and Johnson & Johnson Covid-19 vaccines, citing “possible harmful effects” which are too much of a concern compared to the benefits. |
| The Danish Health Authority declared in a statement that the “balance between possible benefit and possible harmful effects is still not favorable” with the two vaccines, “even when we include assumptions in our analyses that are in favor of the vaccine.” | The Danish Health Authority declared in a statement that the “balance between possible benefit and possible harmful effects is still not favorable” with the two vaccines, “even when we include assumptions in our analyses that are in favor of the vaccine.” |
| It went on to say that based on US and EU data, along with other health authority assessments, the Danish Health Authority can say “with certainty” that both the AstraZeneca and Johnson & Johnson vaccines – known officially as Vaxzevria and Janssen respectively – can cause VITT syndrome, or thrombotic thrombocytopenia. | It went on to say that based on US and EU data, along with other health authority assessments, the Danish Health Authority can say “with certainty” that both the AstraZeneca and Johnson & Johnson vaccines – known officially as Vaxzevria and Janssen respectively – can cause VITT syndrome, or thrombotic thrombocytopenia. |
| “Based on available data, there is no evidence that there is a gender difference in relation to the risk of VITT, but it must generally be assumed that the risk is greater in younger people than in older people,” the Health Authority continued, before concluding that those who still choose to get vaccinated with either of the two vaccines should be informed that they’re “not generally recommended by the National Board of Health.” | “Based on available data, there is no evidence that there is a gender difference in relation to the risk of VITT, but it must generally be assumed that the risk is greater in younger people than in older people,” the Health Authority continued, before concluding that those who still choose to get vaccinated with either of the two vaccines should be informed that they’re “not generally recommended by the National Board of Health.” |
| In April, Denmark became the first European country to permanently suspend its use of the AstraZeneca vaccine after a number of cases of “unusual blood clots, bleeding,” and “low blood platelets counts” in those who had received the jabs. | In April, Denmark became the first European country to permanently suspend its use of the AstraZeneca vaccine after a number of cases of “unusual blood clots, bleeding,” and “low blood platelets counts” in those who had received the jabs. |
| “Our overall assessment is there is a real risk of severe side effects associated with using the Covid-19 vaccine from AstraZeneca,” said Danish Health Authority Director General Soeren Brostroem at the time – the following month, Johnson & Johnson’s vaccine received similar treatment. | “Our overall assessment is there is a real risk of severe side effects associated with using the Covid-19 vaccine from AstraZeneca,” said Danish Health Authority Director General Soeren Brostroem at the time – the following month, Johnson & Johnson’s vaccine received similar treatment. |
| Think your friends would be interested? Share this story! | Think your friends would be interested? Share this story! |
| Dear readers and commenters, | |
| We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
| Sorry for the inconvenience, and looking forward to your future comments, | |
| RT Team. |